Literature DB >> 2735025

Meningococcal infections.

V K Wong, B Agee, K S Kim, H T Wright.   

Abstract

In Los Angeles, a substantial increase in the number of infections due to Neisseria meningitidis has been noted. More alarming has been an associated mortality rate of 21%. The prompt recognition of meningococcal disease based on a high index of suspicion and the early institution of effective antibiotic treatment are essential for preventing complications and reducing mortality.

Entities:  

Mesh:

Year:  1989        PMID: 2735025      PMCID: PMC1026292     

Source DB:  PubMed          Journal:  West J Med        ISSN: 0093-0415


  27 in total

1.  CHRONIC MENINGOCOCCEMIA. CASE REPORT AND REVIEW OF THE LITERATURE.

Authors:  F L BENOIT
Journal:  Am J Med       Date:  1963-07       Impact factor: 4.965

2.  Plasmapheresis for meningococcemia with disseminated intravascular coagulation.

Authors:  W B Scharfman; J R Tillotson; E G Taft; E Wright
Journal:  N Engl J Med       Date:  1979-05-31       Impact factor: 91.245

3.  Bactericidal antibody after colonization with Neisseria meningitidis.

Authors:  L B Reller; R R MacGregor; H N Beaty
Journal:  J Infect Dis       Date:  1973-01       Impact factor: 5.226

4.  Meningococcal purpura: report of 19 patients treated with heparin.

Authors:  P Gérard; M Moriau; A Bachy; P Malvaux; R De Meyer
Journal:  J Pediatr       Date:  1973-05       Impact factor: 4.406

5.  Heparin therapy in fulminant meningococcemia.

Authors:  S S Najjar; M Ahmad
Journal:  J Pediatr       Date:  1969-09       Impact factor: 4.406

6.  Skin manifestations of meningococcal infection; an immediate indicator of prognosis.

Authors:  W H Toews; J W Bass
Journal:  Am J Dis Child       Date:  1974-02

7.  Chronic meningococcemia in childhood. Case report and review of the literature.

Authors:  R L Leibel; J J Fangman; M C Ostrovsky
Journal:  Am J Dis Child       Date:  1974-01

8.  Factors in the prognosis of meningococcal infection. Review of 63 cases with emphasis on recognition and management of the severely ill patient.

Authors:  E R Stiehm; D S Damrosch
Journal:  J Pediatr       Date:  1966-03       Impact factor: 4.406

9.  Human immunity to the meningococcus. II. Development of natural immunity.

Authors:  I Goldschneider; E C Gotschlich; M S Artenstein
Journal:  J Exp Med       Date:  1969-06-01       Impact factor: 14.307

10.  Human immunity to the meningococcus. I. The role of humoral antibodies.

Authors:  I Goldschneider; E C Gotschlich; M S Artenstein
Journal:  J Exp Med       Date:  1969-06-01       Impact factor: 14.307

View more
  1 in total

1.  Oral and intramuscular ceftriaxone for meningococcal infections.

Authors:  S A Billstein; T E Sudol
Journal:  West J Med       Date:  1989-11
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.